PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9506551-3	1998	The activation of these pathways, one activated by IFNgamma and the other by the combination TNFalpha/IL-2/IL-6, is independent from myelin antigens and precedes by 2 weeks phases of disease activity (eg, clinical relapses and/or appearance of gadolinium-enhancing lesions on brain magnetic resonance imaging scans during 1 year of follow-up).	Gadolinium	244-254	interleukin 6	Homo sapiens	107-111	
20102371-3	2010	A short heptapeptide that selectively binds to IL-6R and which inhibits the effect of IL-6 was coupled to the magnetic resonance imaging (MRI) contrast agent gadolinium (Gd)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and the fluorescent dye rhodamine.	Gadolinium	158-170	interleukin 6	Homo sapiens	47-51	
29946640-5	2018	RESULTS: The concentration of IL-6 and TNF-alpha in serum and GCF of patients with GD+CP group was significantly higher than that in CP group and GD group (P<0.05).	Gadolinium	83-85	interleukin 6	Homo sapiens	30-34	
29946640-5	2018	RESULTS: The concentration of IL-6 and TNF-alpha in serum and GCF of patients with GD+CP group was significantly higher than that in CP group and GD group (P<0.05).	Gadolinium	146-148	interleukin 6	Homo sapiens	30-34	
29946640-6	2018	The level of IL-6 and TNF-alpha in serum and GCF of patients in GD+CP group and GD group was positively correlated with FT3 and FT4 (P<0.05), and the correlation between GD+CP group was significantly higher than that in GD group.	Gadolinium	64-66	interleukin 6	Homo sapiens	13-17	
29946640-7	2018	CONCLUSIONS: The level of IL-6 and TNF-alpha in GD+CP group were significantly higher than those in CP group and GD group, indicating that there is an interaction between periodontitis and Graves" disease in immune mechanism.	Gadolinium	48-50	interleukin 6	Homo sapiens	26-30	
22915762-6	2012	cDNA microarray results showed that GD-induced UPR activation promoted upregulation of a number of proangiogenic mediators (VEGF, FGF-2, IL-6, etc.)	Gadolinium	36-38	interleukin 6	Homo sapiens	137-141	
15963050-5	2005	Treatment of bone marrow-derived DCs with GD(3) before lipopolysaccharide-induced maturation decreased the production of interleukin-6 (IL-6), IL-10, IL-12 and tumor necrosis factor-alpha as well as reduced the alloreactivity in mixed leucocyte reaction (MLR).	Gadolinium	42-44	interleukin 6	Homo sapiens	121-134	
15963050-5	2005	Treatment of bone marrow-derived DCs with GD(3) before lipopolysaccharide-induced maturation decreased the production of interleukin-6 (IL-6), IL-10, IL-12 and tumor necrosis factor-alpha as well as reduced the alloreactivity in mixed leucocyte reaction (MLR).	Gadolinium	42-44	interleukin 6	Homo sapiens	136-140